Braeburn Pharmaceuticals (Princeton, N.J.). Braeburn Pharmaceuticals is a commercial stage pharmaceutical company focused on care for underserved populations. Its first product, Probuphine, treats opioid addiction. The company's culture is built on mutual respect and encourages outside-the-box thinking, with team members rewarded for individual contributions and meeting team goals. The company's CEO, Behshad Sheldon, has grown the company from a handful of employees in 2014 to more than 100 employees today. In February 2017, Fast Company named Braeburn one of the top 10 "Most Innovative Companies in Biotech."
